Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis

(2017) Steven D Nathan et al.   Lancet Respiratory Medicine

Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old

(2016) Ganesh Raghu et al.   EUROPEAN RESPIRATORY JOURNAL

Data Resource Profile: Clinical Practice Research Datalink (CPRD)

(2015) Emily Herrett et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improving care for patients with idiopathic pulmonary fibrosis (IPF) in the UK: a round table discussion

(2014) David R Thickett et al.   THORAX

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11

(2014) Ganesh Raghu et al.   Lancet Respiratory Medicine

The Increasing Secondary Care Burden of Idiopathic Pulmonary Fibrosis

(2013) Vidya Navaratnam et al.   CHEST

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Idiopathic pulmonary fibrosis

(2011) Talmadge E King et al.   LANCET

The rising incidence of idiopathic pulmonary fibrosis in the UK

(2011) V. Navaratnam et al.   THORAX

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

(2009) Emily Herrett et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY